Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144807
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2005-09-02
Brief Title:
ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma
Sponsor:
Organization:
Lymphoma Study Association